• Title of article

    Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent

  • Author/Authors

    Sharma، نويسنده , , Natasha and Thomas، نويسنده , , Simmy and Golden، نويسنده , , Encouse B. and Hofman، نويسنده , , Florence M. and Chen، نويسنده , , Thomas C. and Petasis، نويسنده , , Nicos A. and Schِnthal، نويسنده , , Axel H. and Louie، نويسنده , , Stan G.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2012
  • Pages
    12
  • From page
    143
  • To page
    154
  • Abstract
    Autophagy has been recognized as a potential target for cancer therapy. The antimalarial drug chloroquine (CQ) is able to inhibit autophagy and therefore is being considered for cancer therapeutics. However, the relatively low potency of CQ prompted us to investigate whether other lysosomotropic agents might be more effective, and thus potentially more useful. We therefore compared the cytotoxic efficacy of CQ, the quinoline analog mefloquine (MQ), and the fluoroquinolones ciprofloxacin and levofloxacin in several human breast cancer cell lines. We found that MQ was the most potent compound tested; it inhibited autophagy, triggered endoplasmic reticulum stress, and caused cell death in T47D and MDA-MB-231. Altogether, our study demonstrates superior potency of MQ over CQ and the ability of MQ to produce anticancer effects in both hormone receptor positive and negative breast cancer cell lines, suggesting its usefulness in treating various types of cancer.
  • Keywords
    mefloquine , Autophagy , Lysosomotropic agent , CANCER , Chloroquine
  • Journal title
    Cancer Letters
  • Serial Year
    2012
  • Journal title
    Cancer Letters
  • Record number

    1822027